Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jean Bosco N. Elat"'
Autor:
Joseph Fokam, Desire Takou, Ezechiel Ngoufack Jagni Semengue, Georges Teto, Grace Beloumou, Beatrice Dambaya, Maria-Mercedes Santoro, Leonella Mossiang, Serge Clotaire Billong, Fatim Cham, Samuel Martin Sosso, Edith Saounde Temgoua, Aubin Joseph Nanfack, Sylvie Moudourou, Nelly Kamgaing, Rachel Kamgaing, Joelle Nounouce Ngako Pamen, Mireille Mpoudi Ngole Etame, Anne-Cecile Z.-K. Bissek, Jean-Bosco N. Elat, Emmanuel Eben Moussi, Vittorio Colizzi, Carlo-Federico Perno, Alexis Ndjolo, On behalf of the VIROFORUM
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 9, Iss 1, Pp 1-6 (2020)
Abstract Background Sub-Saharan African countries are transitioning to dolutegravir-based regimens, even for patients with extensive previous drug exposure, including first-generation integrase strand-transfer inhibitors (INSTI) such as raltegravir.
Externí odkaz:
https://doaj.org/article/9bcdfcbaba584186827590a5e70f1529
Autor:
Serge C Billong, Georges Nguefack-Tsague, Joseph Fokam, Faran Emmanuel, Shajy Isac, Raoul A T Fodjo, Marie Nicole Ngoufack, Sylvie Kwedi, Laure Vartan Moukam, Thomas Tchetmi, Vincent K Tapka, Alexis Ndjolo, Zara Shubber, Nejma Cheikh, James Blanchard, Jean-Bosco N Elat, Elizabeth N Mziray
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0212315 (2019)
BackgroundDue to high HIV prevalence among Female Sex Workers (FSWs) in Cameroon (36.5%), this population is especially vulnerable to HIV acquisition and transmission nationwide. Though being prioritized in the national HIV response, it would be rele
Externí odkaz:
https://doaj.org/article/e6becf2ccc654bd29067da3323d0eea9
Autor:
Joseph Fokam, Jean-Bosco N Elat, Serge C Billong, Etienne Kembou, Armand S Nkwescheu, Nicolas M Obam, André Essiane, Judith N Torimiro, Gatien K Ekanmian, Alexis Ndjolo, Koulla S Shiro, Anne C Z-K Bissek
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0129210 (2015)
BackgroundThe majority (>95%) of new HIV infection occurs in resource-limited settings, and Cameroon is still experiencing a generalized epidemic with ~122,638 patients receiving antiretroviral therapy (ART). A detrimental outcome in scaling-up ART i
Externí odkaz:
https://doaj.org/article/5ef52ea5a6114efeb5aecb44243cb1b0
Autor:
Serge C Billong, Joseph Fokam, Avelin F Aghokeng, Pascal Milenge, Etienne Kembou, Ibile Abessouguie, Flore Beatrice Meva'a-Onglene, Anne C Zoung-Kanyi Bissek, Vittorio Colizzi, Eitel N Mpoudi, Jean-Bosco N Elat, Koulla S Shiro
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e72680 (2013)
BACKGROUND: Scale-up of antiretroviral therapy (ART) in resource-limited settings has drastically reduced HIV-related morbidity and mortality. However, challenges in long-term ART, adherence and HIV drug resistance (HIVDR) itself, require monitoring
Externí odkaz:
https://doaj.org/article/40bd1a832e34465c98950cbfd7bbb109
Autor:
Nicolas M. Obam, Armand Seraphin Nkwescheu, Gatien K. Ekanmian, Koulla S. Shiro, Andre Essiane, Joseph Fokam, Serge Clotaire Billong, Jean Bosco N. Elat, Alexis Ndjolo, Anne Cecile Zoung-Kanyi Bissek, Judith N. Torimiro, Etienne Kembou
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 6, p e0129210 (2015)
PLoS ONE, Vol 10, Iss 6, p e0129210 (2015)
BackgroundThe majority (>95%) of new HIV infection occurs in resource-limited settings, and Cameroon is still experiencing a generalized epidemic with ~122,638 patients receiving antiretroviral therapy (ART). A detrimental outcome in scaling-up ART i
Autor:
Matthew LeBreton, Valentin Mondoleba, Stefan Baral, Yves Yomb, Ashley Grosso, Laure Vartan Moukam, Ju Nyeong Park, Sethson Kassegne, Serge Clotaire Billong, Sosthenes Ketende, Erin Papworth, Jean Bosco N. Elat, Jules Eloundou, Isaac Macauley
Publikováno v:
BMC Public Health
Background Regular HIV testing is vital for timely linkage to the HIV care continuum and ensuring the success of behavioral and biomedical interventions to prevent HIV acquisition. Men who have sex with men (MSM) are a key population for HIV preventi
Autor:
Anne Cecile Bissek, Vittorio Colizzi, Avelin F. Aghokeng, Zephirin Tsomo, Joseph Fokam, Armand Seraphin Nkwescheu, Ibile Abessouguie, Jean Bosco N. Elat, Etienne Kembou, Serge Clotaire Billong, Pascal Milenge, Grace D Ngute, Peter M. Ndumbe
Publikováno v:
BMC Public Health
Background Rapid scale-up of antiretroviral therapy (ART) and limited access to genotyping assays in low-resource settings (LRS) are inevitably accompanied by an increasing risk of HIV drug resistance (HIVDR). The current study aims to evaluate early